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HD domain phosphohydrolase enzymes are characterized by a
conserved set of histidine and aspartate residues that coordinate
an active site metallocenter. Despite the important roles these
enzymes play in nucleotide metabolism and signal transduction, few
have been both biochemically and structurally characterized. Here,
we present X-ray crystal structures and biochemical characterization
of the Bacillus megaterium HD domain phosphohydrolase OxsA,
involved in the biosynthesis of the antitumor, antiviral, and
antibacterial compound oxetanocin-A. These studies reveal a pre-
viously uncharacterized reaction for this family; OxsA catalyzes the
conversion of a triphosphorylated compound into a nucleoside, re-
leasing one molecule of inorganic phosphate at a time. Remarkably,
this functionality is a result of the OxsA active site, which based on
structural and kinetic analyses has been tailored to bind the small,
four-membered ring of oxetanocin-A over larger substrates. Further-
more, our OxsA structures show an active site that switches from a
dinuclear to a mononuclear metal center as phosphates are elimi-
nated from substrate.
X-ray crystallography | phosphohydrolase | metalloenzymes | natural
products | nucleosides
Oxetanocin-A (OXT) is a nucleoside analog produced byBacillus megaterium NK84-0128 (1) that contains an unusual
four-membered oxetane ring connected to an adenine base through
an N-glycosidic linkage (2). Clinical interest in OXT stems from the
observed activity against hepatitis B virus (3), herpes simplex virus
(1), HIV (4), and human cytomegalovirus (5). This antimicrobial
and antiviral activity may be a consequence of the reported inhi-
bition of cellular and viral DNA polymerases by triphosphorylated
OXT compounds (6). Four genes located within the BglII-D frag-
ment (6.8 kb) of the pOXT1 plasmid isolated from the produc-
ing strain have been hypothesized to encode proteins involved in
OXT production (OxsA and OxsB) and OXT resistance (OxrA
and OxrB) (7).
OxsA is a member of the HD domain superfamily of enzymes.
This superfamily is divided into classes of enzymes that use a
His-Asp doublet of residues and an additional series of con-
served His and Asp residues to coordinate a single divalent
metal (HXnHDXnD motif) (8, 9), a dinuclear metal active site
(HXnHDXnHXnHXnD motif) (10, 11), or a recently described
trinuclear iron metal-center (12). Although in many cases the
identity of the relevant catalytic metal required for chemistry
in vivo is unclear, there are examples of mononuclear enzymes
that can use magnesium (13), cobalt (14), or manganese (8, 13,
15), and dinuclear enzymes that can use nickel (16), manganese
(17), or iron (10, 18–20).
Most of the biochemically characterized HD domain enzymes
catalyze phosphoester bond hydrolysis and are annotated as
phosphohydrolases (8, 9). Their reactions are reasonably diverse
and include hydrolysis of a phosphate from 2′-deoxyadenosine
monophosphate (dAMP) by the Escherichia coli enzyme YfbR
(14), hydrolysis of pyrophosphate from (p)ppGpp (13) or a
deoxyribonucleoside triphosphate (15), and hydrolysis of inorganic
triphosphate from deoxyadenosine triphosphate (dATP) (21, 22).
These enzymes can also cleave the phosphodiester bond of cyclic-
di-GMP (11, 23). Finally, two HD domain enzymes, myo-inositol
oxygenase and PhnZ, are not hydrolases at all. They bind mixed-
valent Fe2+/Fe3+ metal centers and operate as oxygenases,
indicating the chemical diversity possible with the HD domain
fold (10, 18, 20, 24–26).
Here we investigate two plausible mechanistic proposals for the
biosynthesis of OXT through the biochemical and structural char-
acterization of OxsA (Fig. 1). In the first proposal, OxsA catalyzes
the removal of one or multiple phosphates from a phosphorylated
2′-deoxyadenosine derivative, and OxsB, a cobalamin-dependent
S-adenosylmethionine (AdoMet) radical enzyme, catalyzes a radical
rearrangement to form the oxetane ring of OXT. In the second
proposal, OxsB catalyzes ring contraction first, and OxsA works
second to hydrolyze one or multiple phosphates from the phos-
phorylated OXT product.
Results
OxsA Has a Mononuclear HD Domain Phosphohydrolase Fold. The
crystal structure of OxsA was determined to 2.05-Å resolution
using the E72A variant of the E. coli 5′-nucleotidase, YfbR (14),
as a search model. The data collection and refinement statistics
for all determined structures are listed in Table S1. Similar to the
structure of YfbR, OxsA has a globular fold composed of eight
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α-helices (Fig. 2A). There is one monomer of OxsA per asym-
metric unit, but based on an approximate 2,600-Å2 interface
(23% of the total monomeric surface area) between the OxsA
monomer and a symmetry-related molecule, it appears the bio-
logical unit of OxsA is a dimer (Fig. S1). This interface maps to
the dimer interface previously identified in YfbR, formed pre-
dominantly between α-helices 1 and 3 (14). An active site Mg2+
from the crystallization solution is found at the core of the
α-helices, octahedrally coordinated by His31, His66, Asp67, and
Asp132 of the characteristic HXnHDXnD motif, and two water
molecules. Residues Met1, Ile76–Ile97, and Arg191–Asn194
were too disordered to build and are therefore missing from the
refined structure of OxsA.
Structure of OxsA with Oxetanocin 5′-Monophosphate Reveals a
Tailored Active Site Architecture. The structure of OxsA cocrystal-
lized with chemically synthesized oxetanocin-5′-monophosphate
(OxsAOXT-P) was determined to 1.64-Å resolution. The structure of
OxsAOXT-P is similar to the ligand-free structure with an rmsd de-
termined by PyMOL of 0.22 Å for 1,014 atoms. The main dif-
ference between the ligand-bound structure and the ligand-free
structure is the ability to model residues Ile76–Ile97 (Fig. 2A).
Upon binding OXT-P, these residues order to form a short helical
loop following α3 and all of α4, such that only residues 1 and 193–
194 are absent from the OxsAOXT-P structure.
Binding of OXT-P in the active site of OxsA involves interac-
tions between the e-nitrogen of His75 and the C3′-hydroxymethyl
group of OXT, as well as a hydrogen bond between the backbone
amide of Ser78 and the endocyclic oxygen of OXT (Fig. 2B and
Fig. S2A). The active site of OxsAOXT-P is similar to that of YfbR
(Fig. 2C) and contains previously identified important YfbR res-
idues, including: Trp17 (OxsA numbering), a residue proposed to
sterically occlude ribonucleotide binding; Glu70, a residue hy-
pothesized to be involved in protonation of the nucleoside prod-
uct; and Arg16, which positions the 5′-phosphate of the YfbR
substrate, dAMP, for catalysis (14). Consistent with this role, the
guanidinium group of Arg16 of OxsA orients the 5′-phosphate of
OXT-P near Mg2+ and within a positively charged pocket formed
by residues Arg16, Lys81, Lys82, Lys87, Arg94, and Lys161
(Fig. 2B).
Notably, because OxsA and YfbR share only 30% sequence
identity, there are also active site differences. Specifically, His75 of
OxsA, the residue that contacts the C3′-hydroxymethyl group of
OXT, is a catalytically essential Asp in YfbR (Asp77) (14). The
smaller Asp is ideal for accommodating the larger deoxyribose
ring of the YfbR substrate (dAMP) and for hydrogen bonding to
the 3′-hydroxyl moiety of dAMP. In contrast, the larger His resi-
due in OxsA nicely accommodates the smaller four-membered
ring of OXT (Fig. 2C) and hydrogen bonds to Glu70, the equiv-
alent of which is the proposed catalytic acid in YfbR (14). Inter-
estingly, although the phosphates of dAMP and OXT-P occupy
almost identical active site positions (Fig. 2C), the metal positions
are slightly different, resulting in direct interaction between dAMP
and the closer Co2+ in YfbR and a through-water interaction for
OXT-P and Mg2+ in OxsA. Although this variation may be a result
of the difference in the metal that was cocrystallized with the
proteins (Mg2+ in OxsA or Co2+ in YfbR), it should be noted that
an inactive E72A-variant was used to determine the structure of
Co2+-YfbR with dAMP-bound (14), and that E72 (E70 in OxsA)
is very close to the substrate and metal center (Fig. 2C). As de-
scribed below, Co2+ may be the catalytic metal in this site for both
OxsA and YfbR.
Additional differences in the active site of OxsA and YfbR
become evident upon comparison of the electrostatic potential
surfaces; the aforementioned positively charged pocket of OxsA
appears poised to accommodate one or multiple phosphates
(Fig. 2 B and D). In contrast, the active site of YfbR demon-
strates an overall negative charge (Fig. 2E) and, consistent with
this observation, YfbR lacks activity for deoxyribonucleoside di-
and triphosphorylated substrates (14).
OxsA Activity Assays Show Higher in Vitro Activity with Co2+ Than
Mg2+. The phosphatase activity of OxsA was tested against OXT-P
using the malachite green assay, as previously described (27).
Briefly, the assay measures activity using the absorbance of the
Fig. 1. Proposed schemes for OXT biosynthesis using the proteins encoded
by the oxsA and oxsB production genes, which are annotated as an HD
domain phosphohydrolase and a cobalamin-dependent AdoMet radical
enzyme, respectively.
Fig. 2. OxsA has a mononuclear HD domain phos-
phohydrolase protein fold that appears designed to
bind nucleoside analogs with four-membered rings.
(A) The structure of OxsA (blue) is missing residues
Ile76–Ile97, which become ordered in the OxsAOXT-P
structure (cyan). (B) OXT-P binds within the HD domain
active site and interacts with His75 and the backbone
of Ser78. Arg16 orients the 5′-phosphate of OXT-P
near Mg2+ and within a positively charged pocket.
(C) Despite sharing similar architectures, an overlay of
E72A-YfbR (purple) with bound dAMP reveals that the
3′-carbon of dAMP would be located unfavorably
close (1.4 Å) to the e-nitrogen of His75. (D) The overall
positive electrostatic potential of the OxsA active
site. (E) The electrostatic potential measured for the
equivalent pocket of E72A-YfbR (14) shows an overall
negative charge. In D and E, the electrostatic potential
surfaces are displayed on an equivalent scale. Green
and pink spheres represent the divalent metal cocrys-
tallized with OxsA (Mg2+) and E72A-YfbR (Co2+).
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complex formed between ammonium molybdate, malachite green,
and free inorganic phosphate produced from the hydrolysis re-
action. Activity was measured in the presence of Zn2+, Mn2+,
Mg2+, or Co2+ (Fig. 3). Similar to YfbR, Co2+-OxsA is most active
(14, 28), whereas Zn2+-, Mn2+-, and Mg2+-bound OxsA showed
lower levels of activity.
Crystal Structures of OxsA with Multiply Phosphorylated OXT Molecules
Reveal a Change in the Active Site Metal Content. To investigate
whether OxsA is able to bind and turnover multiply phosphory-
lated OXT molecules, as we predicted above based on the positive
electrostatic surface of the OxsA active site, a protocol, which
involved the use of the chemically synthesized OXT-P and the
commercially available enzymes myokinase and pyruvate kinase,
was developed to generate OXT diphosphate (OXT-PP) and
OXT triphosphate (OXT-PPP) (Fig. S3). Using this material, the
structures of OxsAOXT-PP and OxsAOXT-PPP were determined to
1.92- and 1.90-Å resolution, respectively. Similar to the structure
of OxsAOXT-P, residues Ile76–Ile97 are ordered and accommodate
the bound OXT derivatives. In comparison with the OxsAOXT-P
structure, the rmsds determined by PyMOL for the OxsAOXT-PP
and OxsAOXT-PPP structures are 0.16 Å for 1,243 atoms and 0.20 Å
for 1,184 atoms, respectively.
Surprisingly, despite remarkable similarities in the position of
the oxetane ring and adenine base in the active sites of OxsAOXT-P,
OxsAOXT-PP, and OxsAOXT-PPP, the structures with OXT-PP and
OXT-PPP have a second active site Mg2+ (Fig. 4 A–C and Fig. S2).
Because all crystals were grown with the same concentration of
Mg2+, the presence of the second Mg2+ would seem to be due to
the binding of di- and triphosphorylated substrates. As these
compounds likely exist in the cell as Mg2+-complexes, OXT-PP
and OXT-PPP could deliver the second Mg2+ upon binding. Ac-
cordingly, the structure of OxsA with OXT bound (OxsAOXT),
also determined in this work to 1.85-Å resolution, which similar to
OXT-P cannot deliver a metal ion to the active site, shows only
one Mg2+ in the canonical HD-site (Fig. 4D).
In the structure of OxsAOXT-P introduced above, HD residue
Asp132 is found bent 2.8 Å toward the active site metal ion and
away from the negative charge of the 5′-phosphate of OXT-P, and
His66 exhibits two conformations, where in one it serves as a li-
gand to Mg2+ and in the other it is flipped out away from the
metal center, replaced by a water molecule (Fig. 4C). In contrast,
structures with OXT-PP and OXT-PPP show His66 in one con-
formation, ligating the lower HD-site metal ion of the dinuclear
center, and Asp132 serving as a bridging ligand between the
two metal ions (Fig. 4 A and B). The second active site metal ion of
the OxsAOXT-PP structure exhibits an octahedral coordination geome-
try, coordinated by Asp132, one oxygen atom of each the α- and
β- phosphate groups, and three water molecules (Fig. 4B). For the
OxsAOXT-PPP structure, the six-coordinate geometry is fulfilled by
Asp132, one oxygen atom of each the α-, β-, and γ-phosphate
groups, and two water molecules (Fig. 4A). The two metal
centers are separated by 5.3- and 5.2-Å for the OxsAOXT-PP and
OxsAOXT-PPP structures, respectively, which is different from
other HD domain dinuclear sites, which are separated by 3.4–
3.8 Å [PDB ID codes 3TM8 (11), 2IBN (29), 3CCG 2O08,
2OGI, 2PQ7, and 4N6W (18)] and bridged by the HD doublet
Asp residue (Fig. 4 E–G).
OxsA Shows Activity with Di- and Triphosphorylated OXT. The phos-
phatase activity of OxsA was tested against OXT-PP, OXT-PPP,
2′-deoxyadenosine diphosphate (dADP), and dATP using the
malachite green assay described above. Activity is much lower in
the presence of Mg2+ compared with Co2+ (Fig. 5A), explaining
why we did not observe turnover in our crystals. As mentioned
above, capturing the structure of YfbR with substrate and Co2+
required use of inactive mutant protein. Interestingly, a 50:50
Mg2+/Co2+ mixture does not reduce the activity compared with
100% Co2+ (Fig. 5A), suggesting that the highest level of activity
requires Co2+ to be present in only one of the two metal sites.
The kcat of OxsA with OXT-PPP and OXT-PP was 3.8- and 2.4-
fold higher, respectively, than was measured with OXT-P (Table
1). This trend is reflective of what is observed in solution; phos-
phate esters are more stable to hydrolysis than phosphoanhy-
drides. Thus, it does not appear that OxsA has evolved to be a
much better catalyst for one of the phosphorylated forms of OXT
over another. The KM values are similar for all three phosphory-
lated forms of OXT, and are between 8 and 13 μM (Table 1).
Therefore, for the OXT molecules, each added phosphate equates
to an increase in the kcat of OxsA and a corresponding increase in the
kcat/KM. The same is not true for the phosphorylated deoxyadenosine
substrates, for which OxsA activity on dADP was lower than for
both dATP and dAMP (Fig. 5A and Table 1). This difference
could be due in part to the fact that the commercially available
deoxyribonucleotide compounds are less pure (98–100%, ≥95%,
Fig. 3. OxsA activity as measured in the presence of 20 μMOXT-P and 0.6 mM
of the indicated divalent metal ions. Co2+-OxsA shows the highest level of
activity. Error bars represent ± SD of three independent experiments.
Fig. 4. The metal content of the OxsA active site is modulated through sub-
strate binding. (A) OxsAOXT-PPP has a dinuclear center with one Mg2+ found in
the HD-site and the other ligated primarily by substrate. (B) A similar dinuclear
site is observed in OxsAOXT–PP. (C) OxsAOXT–P has a single Mg2+ ligated by the
mononuclear HD domain residues. His66 exhibits two conformations. (D) A
mononuclear site is also observed in the structure of OxsAOXT. (E) Overlay of
OxsAOXT-PPP (dark cyan) with PhnZ (yellow) reveals use of a different Asp as the
bridging ligand of the dinuclear site. (F) Mg2+ in the second site in OxsAOXT-PPP
is 5.2-Å from Mg2+ in the HD-site and has only one protein ligand. (G) The Fe
ions in PhnZ are 3.7 Å apart, bridged by a μ-oxo moiety and a citrate molecule
from the crystallization buffer that binds in place of substrate (18). The second
Fe site has three protein ligands (18). In A–C, the proposed nucleophilic water is
indicated by an asterisk (*). Green, brown, and red spheres correspond to
magnesium, iron, and water molecules, respectively. Stereoviews of OxsAOXT-P,
OxsAOXT-PP, and OxsAOXT-PPP can be found in Fig. S2.
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and ≥97% purity for dAMP, dADP, and dATP, respectively)
than both our chemically and enzymatically synthesized OXT
standards. Importantly, the KM values for dAMP, dADP, and
dATP are 2- to 20-fold higher (22–155 μM) than the KM values
for OXT-P(PP) (Table 1). In the case of dATP (155 ± 18 μM),
the KM is almost equivalent to what has previously been mea-
sured as the concentration in bacterial cells (175–200 μM) (30,
31), indicating OxsA is not a good catalyst for dATP hydrolysis.
A similar study of activity was pursued using HPLC to investigate
production of OXT and deoxyribonucleotide hydrolysis products.
In both cases, the diphosphate, monophosphate, and nucleoside
products were detected consistent with OxsA being able to release
more than one molecule of phosphate from the provided substrates
until the nucleoside products, OXT or 2′-deoxyadeonosine, are
produced (Fig. 5B and Fig. S4).
The observed substrate tolerance of OxsA prompted an in-
vestigation into the B-factors of the OxsA structures with OXT
molecules bound. Within each determined structure, similar
B-factors are observed in the core helices (α1–α3, and α6), which
contribute the HD-metal binding residues. The highest B-factors
are found on the loop following the His75 helix, and on α4-α5
(Fig. S5). Both His75 and Ser78, which form the two principle
interactions with all OXT derivatives in the active site, fall in a
region where the average B-factor is 10–15 Å2 higher than the
average for the entire structure. This flexibility likely allows for
nonoptimal substrates to be accommodated in the active site, albeit
giving rise to higher KM values. Unfortunately, molecular details of
this accommodation are not available, as crystals grown or soaked
with a 5- to 100-fold molar excess of the deoxyribonucleotide
molecules do not reveal any electron density for bound ligands.
Discussion
To study the mechanism by which OxsA and OxsB catalyze the
synthesis of OXT, we have determined the structures of five states
of OxsA (OxsAOXT-PPP, OxsAOXT-PP, OxsAOXT-P, OxsAOXT, and
OxsA) using X-ray crystallography. These structural studies cou-
pled with the malachite green assay of detecting inorganic phos-
phate production, the Michaelis–Menten kinetic measurements,
and the HPLC analysis of hydrolysis product formation are con-
sistent with the proposed scheme B for OXT biosynthesis (shown
in Fig. 1). In this scheme, OxsA catalyzes the hydrolysis of a
phosphorylated OXTmolecule to generate the nucleoside product
of the pathway.
Because of the simple nature of the OXT biosynthetic gene
cluster, first contracting the more thermodynamically stable five-
membered ring of a purine nucleoside coopted from a primary
metabolic pathway to generate the strained, four-membered ring
of OXT, followed by dephosphorylation of an OXT phosphate
may serve as a mechanism to trap the OXT product and thus
prevent its OxsB-catalyzed equilibration with a purine nucleoside
phosphate. Interestingly, it appears that regardless of whether
dAMP, dADP, or dATP is contracted by OxsB, OxsA can catalyze
hydrolysis of the resultant OXT-derivative down to OXT, one
phosphate at a time. The KM values for each of the OXT deriv-
atives are similar, potentially allowing OxsA to hold on to the
phosphorylated forms of OXT until final conversion to OXT is
achieved. From the perspective of chemical warfare between mi-
crobes, the phosphorylated forms of OXT are likely the toxic
species. Indeed, OXT-PPP has been shown to inhibit cellular and
viral DNA polymerases (6). Therefore, it appears that the com-
bined action of OxsA and OxsB generate the warfare agent, OXT,
but renders the compound inert for transport out of the cell.
Consequently, OxsA can be thought of as having a dual function:
OxsA is involved in both completing the biosynthesis of OXT and
imparting resistance to the producing strain. Presumably, OXT is
then taken up by a neighboring organism and rephosphorylated,
thus reacquiring its toxicity. In line with this theory are our results
that promiscuous kinases can be used to enzymatically generate
OXT-PP and OXT-PPP with reasonable yields.
The X-ray crystal structures of OxsA presented in this work add
another level of diversity to the HD domain superfamily; the ac-
tive site appears to be designed to bind the secondary metabolite
OXT and also decrease the binding affinity of substrates with
larger deoxyribose rings. This design is accomplished by the use of
a bulky His residue near the HD-active site metal ion in place of
the equivalent Asp found in YfbR. Notably, however, this enzyme
redesign places His75 in a highly flexible region of the protein,
which when not bound with OXT, affords enzymatic promiscuity,
allowing hydrolysis of deoxyribonucleotide substrates, albeit with
lower catalytic efficiency (a consequence of the presumed de-
crease in substrate affinity illustrated by the measured KM values).
Fig. 5. OxsA activity on phosphorylated OXT and deoxyadenosine compounds.
(A) The activity of OxsA is plotted as a function of tested substrate (10 molar
equivalents) in the presence of Co2+, Mg2+, or a Co2+/Mg2+ mixture. Error bars
represent the ± SD of three independent experiments. (B) HPLC analysis of OxsA
hydrolysis products when incubated with OXT derivatives (OXT-PPP, OXT-PP, or
OXT-P). Each red trace corresponds to an OXT derivative standard. The blue
traces correspond to hydrolysis products after incubation of the OXT derivative
with OxsA. Current LC-MS data indicates splitting of the nucleoside peak is
because of hydroxylation that occurs under the HPLC assay conditions.
Table 1. Summary of kinetic parameters for OxsA with OXT- and deoxyribonucleotide
compounds
Tested substrate KM (μM) Vmax × 10−3 (U/mg)* kcat × 10−3 (s−1) kcat/KM (M−1·s−1)
OXT-P 11 ± 3 3.2 ± 0.20 1.2 ± 0.077 106 ± 30
dAMP 22 ± 2 9.8 ± 0.24 3.7 ± 0.094 167 ± 16
OXT-PP 13 ± 3 7.8 ± 0.46 2.9 ± 0.17 221 ± 47
dADP 53 ± 11 7.1 ± 0.35 2.6 ± 0.13 51 ± 10
OXT-PPP 8 ± 2 12 ± 0.86 4.5 ± 0.33 525 ± 121
dATP 155 ± 18 58 ± 2.4 22 ± 0.83 142 ± 17
See SI Materials and Methods for experimental details.
*U/mg = μmol/min mg of OxsA.
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The enzyme YedJ, which also has a His residue in the equivalent
position, similarly shows poor activity with primary metabolic
phosphatase and phosphodiesterase substrates (14).
Perhaps even more impressive is the revelation from this
structural work that an HD domain scaffold can accommodate
more than one type of metal center depending on which substrate
is bound. Before this work, there were characterized HD domain
enzymes, which use mono‐ (14, 15, 21, 22, 32, 33), di- (10, 11, 16–
18, 23, 24, 29, 34), and trinuclear (12) metal centers, but no ex-
amples that use “switchable” metallocenters nor examples of
dinuclear sites that resemble the one that we observe here. We
hypothesize that this second metal center is introduced as a con-
sequence of binding a Mg2+-OXT di- or triphosphate molecule.
As discussed below, the use of a second metal site extends the
hydrolytic capabilities of the active site, allowing OxsA to catalyze
three-phosphate elimination reactions at the α-, β-, and γ-positions
of its substrate. The observed mono- to di-nuclear metal switching
mechanism of OxsA is vaguely reminiscent of RNA polymerase II,
which requires two Mg2+ ions that are bridged by an Asp and
located 5.8 Å apart; one Mg2+ remains bound to the enzyme and
one Mg2+ is only stably bound in the presence of a nucleotide
substrate (35, 36). Unlike OxsA, however, in RNA polymerase II
the stable Mg2+ has three Asp ligands and coordinates the
α-phosphate of the substrate, and the transient Mg2+ has addi-
tional protein ligands (35, 36).
Mechanistically, the vast majority of phosphate elimination re-
actions proceed through an in-line attack by a nucleophile, at the
phosphorus atom, opposite the position of the leaving group (37).
This type of reaction is one proposal for YfbR, where hydrolysis
requires that the 5′-phosphate of dAMP coordinates the HD-
metal center, and is thereby positioned for nucleophilic attack by a
Co2+ bound hydroxide ion, followed by, or with concomitant
protonation of the leaving group by Glu72 (Glu70 in OxsA num-
bering) (14). Based on the X-ray crystal structures determined
here, it can be intuited how OxsA could use a similar mechanism
to catalyze three sequential hydrolysis reactions with the involvement
of three different water molecules (starred in Fig. 4) and a flexible
dinuclear motif that has only one protein-based ligand to the
second metal ion.
With respect to hydrolysis of the γ-phosphate of OXT-PPP, a
water molecule bound to the metal ion in the canonical HD-site is
positioned correctly to serve as the nucleophile (Fig. 4A). Metal
ions act as Lewis acids, lowering the pKa of bound water molecules
and activating them for nucleophilic attack on phosphorylated
compounds. For hydrolysis of the β-phosphate, a water molecule
bound to the metal ion in the noncanonical site meets the requi-
site geometric requirement (Fig. 4B). Accordingly, even if this
second metal ion binds as part of the substrate, the active site does
require its presence for hydrolysis of OXT-PP. Loss of this
second metal site is expected to occur along with or following
hydrolysis of the β-phosphate. The remaining phosphate of OXT-P
moves down to occupy the second metal site, repositioning Asp132
(Fig. S6A). An exit route for the metal ion can be visualized in a
surface representation of the dinuclear OxsA protein, which
reveals that the second site is much more solvent accessible than
the HD-site (Fig. S6B) as well as a typical HD domain second
metal site (Fig. S7).
In part because of the transient nature of the second metal site
in OxsA, we propose that Mg2+ and not Co2+ is the relevant
noncanonical metal in vivo. Our data show that Co2+-OxsA and
Co2+/Mg2+-OxsA have similarly high levels of activity, indicat-
ing that Co2+ need not occupy both sites for maximum turnover.
Additionally, Co2+ decreases cellular growth rate and becomes
toxic to B. megaterium at levels above 50 μM (38), whereas Mg2+
is typically present in the millimolar range in cells (39) and
commonly associated with phosphorylated molecules. Although
it is possible that the physiologically relevant metal in both sites
is Mg2+, B. megaterium is a major producer of cobalamin (40),
requiring a cellular flux of Co2+ that should be sufficient to fill a
canonical and stable metal site. For these reasons, we suggest
that the dinuclear site is composed of Co2+ in the canonical HD-
site and Mg2+ in the noncanonical, transient secondary site,
which is introduced with OXT-PP and OXT-PPP substrates.
Finally, for hydrolysis of the α-phosphate, a water bound to the
metal in the HD-site is positioned appropriately (3.6 Å from the
phosphorus atom) (Fig. 4C). In addition to metal-catalyzed wa-
ter activation, the enzymatic mechanism may involve modulation
of the electrophilicity of the phosphate to be hydrolyzed, as our
structures show an overall positive active site electrostatic po-
tential (Fig. 2D) created by a number of Lys and Arg residues in
addition to the metal ions that are present (Fig. 2C).
Although OxsA appears tailored to perform hydrolysis reactions
on three different forms of the secondary metabolite OXT, likely
using three different water molecules bound to metal ions in two
different metal-binding sites, OxsA is neither highly specific nor
highly active. For example, the specific activity of Co2+-OxsA is
∼85 times slower than that observed for YfbR with its native
substrate dAMP (14). Even though primary metabolic enzymes
are often faster than ones involved in secondary metabolism,
OxsA rates of 0.0012–0.022 s−1 (0.072–1.3 min−1) (Table 1) still
seem modest. Although turnover numbers for OxsA’s partner
enzyme, OxsB, have not yet been reported, AdoMet radical en-
zymes are notoriously slow. A recent review article reports that
rates are typically on the order of 0.018–1.6 min−1 (41). If OxsB
turns out to be a typical AdoMet radical enzyme, it seems likely
that there would have been little evolutionary pressure to evolve
OxsA to turn over phosphorylated OXT molecules much faster
than they are being produced. A biochemical characterization of
OxsB will be informative in this regard.
There are currently ∼100,000 protein X-ray crystal structures
deposited in the PDB. Despite this large number, it has been es-
timated that fewer than 1,000 unique protein folds exist (42). This
discrepancy means that protein scaffolds must be reused and
reinvented for new catalytic functions through divergent or con-
vergent evolution (8, 43). One theory for how Nature repurposes
protein architectures is that it selects from a pool of enzymes with
mechanisms that would lend a strategy for catalysis of a new re-
action (43). Often, this approach is at the expense of a lower
enzymatic rate and catalytic promiscuity for the original substrate
(43). Similar to the production of OXT, a toxic compound, the
redesign of an enzyme has the ability to give the host a competitive
advantage (43). These concepts are exemplified by the HD do-
main enzyme superfamily whose catalytic repertoire is just starting
to be unveiled. Here, we report a customized HD domain active
site architecture and a switchable metallocenter, which is reg-
ulated by the binding of OXT substrates. These studies reveal
the function of OxsA and serve to elucidate a scheme for a two-
enzyme catalyzed biosynthesis of the nucleoside analog OXT.
Materials and Methods
The oxsA gene was synthesized by Mr. Gene with codon optimization for
E. coli expression, subcloned into the pET24b(+) vector, and transformed
into E. coli BL21-star-(DE3). OxsA was purified using ammonium sulfate
precipitation and a DEAE-Sepharose CL-6B column. OXT and OXT-P were
chemically synthesized (Scheme S1), whereas OXT-PP and OXT-PPP were
enzymatically generated. Inorganic phosphate production was measured
using the absorbance of malachite green at 630 nm (27). The OxsA reaction
products were detected at 260 nm following separation on an analytical
C-18 reverse-phase HPLC column. The structure of OxsA was solved using the
structure of YfbR (14) as a molecular replacement model. The structure of
OxsA was used to determine the structure of OxsAOXT, which was used to
determine the structures of OxsAOXT-P, OxsAOXT-PP, and OxsAOXT-PPP. Detailed
protocols can be found in SI Materials and Methods.
ACKNOWLEDGMENTS. This work was supported by National Institute of
Health Grants F32-GM108189 (to J.B.-R.) and GM035906 (to H.-w.L.), and
Welch Foundation Grant F-1511 (to H.-w.L.). C.L.D. is a Howard Hughes Med-
ical Institute Investigator. This work is based upon research conducted at the
13754 | www.pnas.org/cgi/doi/10.1073/pnas.1613610113 Bridwell-Rabb et al.
Northeastern Collaborative Access Team beamlines, which are funded by the
National Institute of General Medical Sciences from the National Institutes of
Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is
funded by a NIH-Office of Research Infrastructure Programs High-End Instru-
mentation Grant S10 RR029205. This research used resources of the Advanced
Photon Source, a US Department of Energy (DOE) Office of Science User
Facility operated for the DOE Office of Science by Argonne National Lab-
oratory under Contract DE-AC02-06CH11357. This work also includes research
conducted at the Stanford Synchrotron Radiation Lightsource. Use of the Stan-
ford Synchrotron Radiation Lightsource, SLAC National Accelerator Labora-
tory, is supported by the US DOE, Office of Science, Office of Basic Energy
Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radi-
ation Lightsource Structural Molecular Biology Program is supported by the
DOE Office of Biological and Environmental Research, and by the National
Institutes of Health, National Institute of General Medical Sciences (including
P41GM103393).
1. Shimada N, et al. (1986) Oxetanocin, a novel nucleoside from bacteria. J Antibiot
(Tokyo) 39(11):1623–1625.
2. Nakamura H, et al. (1986) The X-ray structure determination of oxetanocin. J Antibiot
(Tokyo) 39(11):1626–1629.
3. Ueda K, Tsurimoto T, Nagahata T, Chisaka O, Matsubara K (1989) An in vitro system
for screening anti-hepatitis B virus drugs. Virology 169(1):213–216.
4. Hoshino H, Shimizu N, Shimada N, Takita T, Takeuchi T (1987) Inhibition of infectivity
of human immunodeficiency virus by oxetanocin. J Antibiot (Tokyo) 40(7):1077–1078.
5. Nishiyama Y, Yamamoto N, Takahash K, Shimada N (1988) Selective inhibition of
human cytomegalovirus replication by a novel nucleoside, oxetanocin G. Antimicrob
Agents Chemother 32(7):1053–1056.
6. Izuta S, et al. (1992) Inhibitory effects of triphosphate derivatives of oxetanocin G and
related compounds on eukaryotic and viral DNA polymerases and human immuno-
deficiency virus reverse transcriptase. J Biochem 112(1):81–87.
7. Morita M, et al. (1999) Cloning of oxetanocin A biosynthetic and resistance genes that
reside on a plasmid of Bacillus megaterium strain NK84-0128. Biosci Biotechnol
Biochem 63(3):563–566.
8. Galperin MY, Koonin EV (2012) Divergence and convergence in enzyme evolution.
J Biol Chem 287(1):21–28.
9. Aravind L, Koonin EV (1998) The HD domain defines a new superfamily of metal-
dependent phosphohydrolases. Trends Biochem Sci 23(12):469–472.
10. Brown PM, et al. (2006) Crystal structure of a substrate complex of myo-inositol
oxygenase, a di-iron oxygenase with a key role in inositol metabolism. Proc Natl Acad
Sci USA 103(41):15032–15037.
11. Lovering AL, Capeness MJ, Lambert C, Hobley L, Sockett RE (2011) The structure of an
unconventional HD-GYP protein from Bdellovibrio reveals the roles of conserved
residues in this class of cyclic-di-GMP phosphodiesterases. MBio 2(5):e00163-11.
12. Bellini D, et al. (2014) Crystal structure of an HD-GYP domain cyclic-di-GMP phos-
phodiesterase reveals an enzyme with a novel trinuclear catalytic iron centre. Mol
Microbiol 91(1):26–38.
13. Heinemeyer EA, Richter D (1977) In vitro degradation of guanosine tetraphosphate
(ppGpp) by an enzyme associated with the ribosomal fraction from Escherichia coli.
FEBS Lett 84(2):357–361.
14. Zimmerman MD, Proudfoot M, Yakunin A, Minor W (2008) Structural insight into the
mechanism of substrate specificity and catalytic activity of an HD-domain phospho-
hydrolase: The 5′-deoxyribonucleotidase YfbR from Escherichia coli. J Mol Biol 378(1):
215–226.
15. Jeon YJ, et al. (2016) Structural and biochemical characterization of bacterial YpgQ
protein reveals a metal-dependent nucleotide pyrophosphohydrolase. J Struct Biol
195(1):113–122.
16. Yakunin AF, et al. (2004) The HD domain of the Escherichia coli tRNA nucleotidyl-
transferase has 2′,3′-cyclic phosphodiesterase, 2′-nucleotidase, and phosphatase ac-
tivities. J Biol Chem 279(35):36819–36827.
17. Sultan SZ, et al. (2011) Analysis of the HD-GYP domain cyclic dimeric GMP phospho-
diesterase reveals a role in motility and the enzootic life cycle of Borrelia burgdorferi.
Infect Immun 79(8):3273–3283.
18. Wörsdörfer B, et al. (2013) Organophosphonate-degrading PhnZ reveals an emerging
family of HD domain mixed-valent diiron oxygenases. Proc Natl Acad Sci USA 110(47):
18874–18879.
19. Miner KD, Klose KE, Kurtz DM, Jr (2013) An HD-GYP cyclic di-guanosine mono-
phosphate phosphodiesterase with a non-heme diiron-carboxylate active site.
Biochemistry 52(32):5329–5331.
20. Xing G, et al. (2006) A coupled dinuclear iron cluster that is perturbed by substrate
binding in myo-inositol oxygenase. Biochemistry 45(17):5393–5401.
21. Goldstone DC, et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside
triphosphate triphosphohydrolase. Nature 480(7377):379–382.
22. Vorontsov II, et al. (2011) Characterization of the deoxynucleotide triphosphate tri-
phosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus fae-
calis and crystal structure of the activator-substrate complex. J Biol Chem 286(38):
33158–33166.
23. Ryan RP, et al. (2006) Cell-cell signaling in Xanthomonas campestris involves an HD-
GYP domain protein that functions in cyclic di-GMP turnover. Proc Natl Acad Sci USA
103(17):6712–6717.
24. Bollinger JM, Jr, Diao Y, Matthews ML, Xing G, Krebs C (2009) myo-Inositol oxygen-
ase: A radical new pathway for O(2) and C-H activation at a nonheme diiron cluster.
Dalton Trans (6):905–914.
25. McSorley FR, et al. (2012) PhnY and PhnZ comprise a new oxidative pathway for
enzymatic cleavage of a carbon-phosphorus bond. J Am Chem Soc 134(20):8364–8367.
26. Xing G, et al. (2006) Oxygen activation by a mixed-valent, diiron(II/III) cluster in the glycol
cleavage reaction catalyzed by myo-inositol oxygenase. Biochemistry 45(17):5402–5412.
27. Baykov AA, Evtushenko OA, Avaeva SM (1988) A malachite green procedure for
orthophosphate determination and its use in alkaline phosphatase-based enzyme
immunoassay. Anal Biochem 171(2):266–270.
28. Proudfoot M, et al. (2004) General enzymatic screens identify three new nucleotid-
ases in Escherichia coli. Biochemical characterization of SurE, YfbR, and YjjG. J Biol
Chem 279(52):54687–54694.
29. Thorsell AG, et al. (2008) Structural and biophysical characterization of human myo-
inositol oxygenase. J Biol Chem 283(22):15209–15216.
30. Buckstein MH, He J, Rubin H (2008) Characterization of nucleotide pools as a function
of physiological state in Escherichia coli. J Bacteriol 190(2):718–726.
31. Bochner BR, Ames BN (1982) Complete analysis of cellular nucleotides by two-dimensional
thin layer chromatography. J Biol Chem 257(16):9759–9769.
32. Kondo N, et al. (2007) Structure of dNTP-inducible dNTP triphosphohydrolase: Insight
into broad specificity for dNTPs and triphosphohydrolase-type hydrolysis. Acta
Crystallogr D Biol Crystallogr 63(Pt 2):230–239.
33. Hogg T, Mechold U, Malke H, Cashel M, Hilgenfeld R (2004) Conformational antag-
onism between opposing active sites in a bifunctional RelA/SpoT homolog modulates
(p)ppGpp metabolism during the stringent response [corrected]. Cell 117(1):57–68.
Erratum in Cell (2004) 117(3):415.
34. van Staalduinen LM, et al. (2014) Crystal structure of PhnZ in complex with substrate
reveals a di-iron oxygenase mechanism for catabolism of organophosphonates. Proc
Natl Acad Sci USA 111(14):5171–5176.
35. Cramer P, Bushnell DA, Kornberg RD (2001) Structural basis of transcription: RNA
polymerase II at 2.8 angstrom resolution. Science 292(5523):1863–1876.
36. Westover KD, Bushnell DA, Kornberg RD (2004) Structural basis of transcription:
Nucleotide selection by rotation in the RNA polymerase II active center. Cell 119(4):
481–489.
37. Frey PA (1982) Stereochemistry of enzymatic-reactions of phosphates. Tetrahedron
38(11):1541–1567.
38. Moore SJ, Mayer MJ, Biedendieck R, Deery E, Warren MJ (2014) Towards a cell factory
for vitamin B12 production in Bacillus megaterium: Bypassing of the cobalamin ri-
boswitch control elements. N Biotechnol 31(6):553–561.
39. Sissi C, Palumbo M (2009) Effects of magnesium and related divalent metal ions in
topoisomerase structure and function. Nucleic Acids Res 37(3):702–711.
40. Raux E, Lanois A, Warren MJ, Rambach A, Thermes C (1998) Cobalamin (vitamin B12)
biosynthesis: Identification and characterization of a Bacillus megaterium cobI op-
eron. Biochem J 335(Pt 1):159–166.
41. Broderick JB, Duffus BR, Duschene KS, Shepard EM (2014) Radical S-adenosylmethionine
enzymes. Chem Rev 114(8):4229–4317.
42. Wolf YI, Grishin NV, Koonin EV (2000) Estimating the number of protein folds and
families from complete genome data. J Mol Biol 299(4):897–905.
43. Gerlt JA, Babbitt PC (2001) Divergent evolution of enzymatic function: mechanisti-
cally diverse superfamilies and functionally distinct suprafamilies. Annu Rev Biochem
70:209–246.
44. Norbeck DW, Kramer JB (1988) Synthesis of (-)-Oxetanocin. J Am Chem Soc 110(21):
7217–7218.
45. Otwinowski Z, et al. (1997) Processing of X-ray diffraction data collected in oscillation
mode. Methods Enzymol 276:307–326.
46. Bunkóczi G, Read RJ (2011) Improvement of molecular-replacement models with
Sculptor. Acta Crystallogr D Biol Crystallogr 67(Pt 4):303–312.
47. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for
macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):
213–221.
48. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta
Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2126–2132.
49. Moriarty NW, Grosse-Kunstleve RW, Adams PD (2009) Electronic Ligand Builder and
Optimization Workbench (eLBOW): A tool for ligand coordinate and restraint gen-
eration. Acta Crystallogr D Biol Crystallogr 65(Pt 10):1074–1080.
50. Morin A, et al. (2013) Collaboration gets the most out of software. eLife 2:e01456.
51. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial
restraints. J Mol Biol 234(3):779–815.
52. Dolinsky TJ, et al. (2007) PDB2PQR: Expanding and upgrading automated preparation
of biomolecular structures for molecular simulations. Nucleic Acids Res 35(Web Server
issue):W522–525.
53. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: An automated
pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids
Res 32(Web Server issue):W665–667.
54. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nano-
systems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98(18):
10037–10041.
Bridwell-Rabb et al. PNAS | November 29, 2016 | vol. 113 | no. 48 | 13755
BI
O
CH
EM
IS
TR
Y
